
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
NSUN2 promotes osteosarcoma progression by enhancing the stability of FABP5 mRNA via m5C methylation
Min Yang, Renxiong Wei, Sheng Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 35
Min Yang, Renxiong Wei, Sheng Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Metabolic Recoding of NSUN2‐Mediated m5C Modification Promotes the Progression of Colorectal Cancer via the NSUN2/YBX1/m5C‐ENO1 Positive Feedback Loop
Baoxiang Chen, Yanrong Deng, Yuntian Hong, et al.
Advanced Science (2024) Vol. 11, Iss. 28
Open Access | Times Cited: 25
Baoxiang Chen, Yanrong Deng, Yuntian Hong, et al.
Advanced Science (2024) Vol. 11, Iss. 28
Open Access | Times Cited: 25
NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization
Shaomin Zou, Yizhi Huang, Ziqing Yang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 17
Shaomin Zou, Yizhi Huang, Ziqing Yang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 17
Critical roles and clinical perspectives of RNA methylation in cancer
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 17
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 17
Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m5C modification of SLC7A11 mRNA
Shuai-Jun Chen, Jun Zhang, Ting Zhou, et al.
Redox Biology (2023) Vol. 69, pp. 102975-102975
Open Access | Times Cited: 37
Shuai-Jun Chen, Jun Zhang, Ting Zhou, et al.
Redox Biology (2023) Vol. 69, pp. 102975-102975
Open Access | Times Cited: 37
NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization
Zhen Zhao, Yujie Zhou, Peng Lv, et al.
Cancer Letters (2024) Vol. 597, pp. 217059-217059
Open Access | Times Cited: 9
Zhen Zhao, Yujie Zhou, Peng Lv, et al.
Cancer Letters (2024) Vol. 597, pp. 217059-217059
Open Access | Times Cited: 9
LncRNA HOST2 promotes NSUN2-mediated breast cancer progression via interaction with ELAVL1
Xuehui Wang, Diya Liu, Kaiyao Hua, et al.
Cellular Signalling (2024) Vol. 117, pp. 111112-111112
Closed Access | Times Cited: 7
Xuehui Wang, Diya Liu, Kaiyao Hua, et al.
Cellular Signalling (2024) Vol. 117, pp. 111112-111112
Closed Access | Times Cited: 7
NSUN2 promotes lung adenocarcinoma progression through stabilizing PIK3R2 mRNA in an m5C‐dependent manner
Xuan Du, Cheng Cheng, Yi Yang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 5, pp. 962-976
Closed Access | Times Cited: 7
Xuan Du, Cheng Cheng, Yi Yang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 5, pp. 962-976
Closed Access | Times Cited: 7
Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma
Yan Peng, Jie Wang, Bin Yue, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189171-189171
Closed Access | Times Cited: 6
Yan Peng, Jie Wang, Bin Yue, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189171-189171
Closed Access | Times Cited: 6
Biological function molecular pathways and druggability of DNMT2/TRDMT1
Huari Li, Huiru Liu, Dai-Yun Zhu, et al.
Pharmacological Research (2024) Vol. 205, pp. 107222-107222
Open Access | Times Cited: 5
Huari Li, Huiru Liu, Dai-Yun Zhu, et al.
Pharmacological Research (2024) Vol. 205, pp. 107222-107222
Open Access | Times Cited: 5
Lipid metabolic reprogramming and associated ferroptosis in osteosarcoma: From molecular mechanisms to potential targets
Zhongbao Yin, Guanlu Shen, Minjie Fan, et al.
Journal of bone oncology (2025), pp. 100660-100660
Open Access
Zhongbao Yin, Guanlu Shen, Minjie Fan, et al.
Journal of bone oncology (2025), pp. 100660-100660
Open Access
RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway
Zhun Wei, Kezhou Xia, Di Zheng, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 12
Zhun Wei, Kezhou Xia, Di Zheng, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 12
ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner
Jinhao Chen, Mujie Ye, Jian’an Bai, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Jinhao Chen, Mujie Ye, Jian’an Bai, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Biomaterials‐Boosted Immunotherapy for Osteosarcoma
Chao Sun, Shuqiang Li, Jianxun Ding
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 4
Chao Sun, Shuqiang Li, Jianxun Ding
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 4
Post‐Translational Modifications of RNA‐Modifying Proteins in Cellular Dynamics and Disease Progression
Yunfan Lin, Pei Lin, Ye Lu, et al.
Advanced Science (2024) Vol. 11, Iss. 44
Open Access | Times Cited: 4
Yunfan Lin, Pei Lin, Ye Lu, et al.
Advanced Science (2024) Vol. 11, Iss. 44
Open Access | Times Cited: 4
Identification and validation of an m5C-related lncRNA signature for predicting prognosis and immune response in clear cell renal cell carcinoma
Shan Ao, Leqi Liang, Peng Lei, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Shan Ao, Leqi Liang, Peng Lei, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Identification and characterization of mitochondrial autophagy-related genes in osteosarcoma and predicting clinical prognosis
Hongliang Zhang, Jingyu Zhang, Kai Zhu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Hongliang Zhang, Jingyu Zhang, Kai Zhu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
NSUN2 promotes colorectal cancer progression and increases lapatinib sensitivity by enhancing CUL4B/ErbB‐STAT3 signalling in a non‐m5C manner
Yuanbo Hu, Chenbin Chen, Kezhi Lin, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
Yuanbo Hu, Chenbin Chen, Kezhi Lin, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access
Nsun2 Promotes Pm2.5-Induced Epithelial-Mesenchymal Transition Through Methylating Chitinase 3-Like-1 Mrna
Mengyao Shao, Chunjiang Li, Jingyi Li, et al.
(2025)
Closed Access
Mengyao Shao, Chunjiang Li, Jingyi Li, et al.
(2025)
Closed Access
Dongxing Shao, Cihang Liu, Y. Wang, et al.
The FASEB Journal (2023) Vol. 37, Iss. 12
Open Access | Times Cited: 8
Deciphering the vital roles and mechanism of m5C modification on RNA in cancers.
Lemei Zheng, Yumei Duan, Mengna Li, et al.
PubMed (2023) Vol. 13, Iss. 12, pp. 6125-6146
Closed Access | Times Cited: 7
Lemei Zheng, Yumei Duan, Mengna Li, et al.
PubMed (2023) Vol. 13, Iss. 12, pp. 6125-6146
Closed Access | Times Cited: 7
Spatiotemporal evolutionary process of osteosarcoma immune microenvironment remodeling and C1QBP‐driven drug resistance deciphered through single‐cell multi‐dimensional analysis
Xin Wu, Ning Tang, Qiangqiang Zhao, et al.
Bioengineering & Translational Medicine (2024) Vol. 9, Iss. 5
Open Access | Times Cited: 2
Xin Wu, Ning Tang, Qiangqiang Zhao, et al.
Bioengineering & Translational Medicine (2024) Vol. 9, Iss. 5
Open Access | Times Cited: 2
NSUN2-mediated RNA methylation: Molecular mechanisms and clinical relevance in cancer
Penghui Li, Di Huang
Cellular Signalling (2024) Vol. 123, pp. 111375-111375
Closed Access | Times Cited: 2
Penghui Li, Di Huang
Cellular Signalling (2024) Vol. 123, pp. 111375-111375
Closed Access | Times Cited: 2
Disease Diagnosis Based on Nucleic Acid Modifications
Xiaochen Xue, Zhiying Wang, Yafen Wang, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 10, pp. 2114-2127
Closed Access | Times Cited: 5
Xiaochen Xue, Zhiying Wang, Yafen Wang, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 10, pp. 2114-2127
Closed Access | Times Cited: 5
Loss of NSUN6 inhibits osteosarcoma progression by downregulating EEF1A2 expression and activation of Akt/mTOR signaling pathway via m5C methylation
Sang Hu, Min Yang, Kang-Wen Xiao, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 4
Sang Hu, Min Yang, Kang-Wen Xiao, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 4